Excelsoft Technologies Ltd
- Market Cap ₹ 902 Cr.
- Current Price ₹ 78.4
- High / Low ₹ 143 / 68.0
- Stock P/E 23.6
- Book Value ₹ 33.1
- Dividend Yield 0.00 %
- ROCE 16.4 %
- ROE 10.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 50.5% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.83% over last 3 years.
- Contingent liabilities of Rs.472 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Information Technology Information Technology IT - Services IT Enabled Services
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 99 | 157 | 196 | 193 | 233 | |
| 63 | 92 | 128 | 140 | 160 | |
| Operating Profit | 36 | 65 | 67 | 53 | 73 |
| OPM % | 37% | 41% | 34% | 27% | 31% |
| 1 | 2 | 3 | 2 | 15 | |
| Interest | 13 | 14 | 13 | 10 | 5 |
| Depreciation | 22 | 24 | 26 | 28 | 25 |
| Profit before tax | 3 | 29 | 30 | 18 | 59 |
| Tax % | 278% | 35% | 25% | 32% | 42% |
| -6 | 19 | 23 | 12 | 34 | |
| EPS in Rs | -37.40 | 116.97 | 142.38 | 76.25 | 3.40 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 14% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 50% |
| 3 Years: | 22% |
| TTM: | 180% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 8% |
| Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 100 | 100 |
| Reserves | 209 | 252 | 274 | 293 | 266 | 281 |
| 168 | 131 | 118 | 77 | 35 | 45 | |
| 38 | 36 | 41 | 47 | 69 | 67 | |
| Total Liabilities | 417 | 420 | 435 | 418 | 470 | 493 |
| 346 | 330 | 332 | 320 | 122 | 118 | |
| CWIP | 11 | 13 | 0 | 0 | 0 | 0 |
| Investments | 2 | 2 | 2 | 2 | 15 | 15 |
| 58 | 75 | 101 | 96 | 333 | 360 | |
| Total Assets | 417 | 420 | 435 | 418 | 470 | 493 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 28 | 60 | 54 | 53 | 50 | |
| -123 | -24 | -15 | -16 | 8 | |
| 95 | -35 | -26 | -51 | -56 | |
| Net Cash Flow | 0 | 1 | 13 | -14 | 2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 114 | 91 | 86 | 87 | 87 |
| Inventory Days | |||||
| Days Payable | |||||
| Cash Conversion Cycle | 114 | 91 | 86 | 87 | 87 |
| Working Capital Days | -154 | -89 | -47 | 9 | 15 |
| ROCE % | 11% | 7% | 16% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Average Vintage of Top 10 Clients Years |
|
||
| Employee Utilisation Rate Percentage |
|||
| New Client Additions Count |
|||
| Number of Clients Count |
|||
| Number of Employees Count |
|||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Directorate
2d - Appointed Dr. Jayakumar Karuppusamy as Additional Independent Director from March 10, 2026; Audit Committee chair changed to Shivkumar Divate.
-
Board Meeting Outcome for Outcome Of The Board Meeting - Appointment Of Dr. Jayakumar Karuppusamy (DIN: 03615535) As An Additional Director (Non-Executive Independent Director) Of The Company.
2d - Appointed Dr. Jayakumar Karuppusamy as independent director from March 10, 2026 for five-year term; committees reconstituted.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 Mar
-
New Product Launch
17 Feb - Launched Saras Assessments in a Box on Feb 17, 2026; assessment and proctoring solution, available globally.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
12 Feb - CARE report for quarter ended Dec 31, 2025: Rs180 crore IPO, Rs45.30 crore utilized, Rs134.70 crore unutilized invested in FDs.
Concalls
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT REC